[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342964-105":59,"doc-detail-342964-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","transcriptomics-based-liquid-biopsy-panel-for-early-non-invasive-identification-of-peritoneal-recurrence-and-micrometastasis-in-locally-advanced-gastric-cancer","Transcriptomics-based liquid biopsy panel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer","","A transcriptomics-driven liquid biopsy approach was developed to enable earlier, noninvasive detection and risk stratification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer. Genome-wide transcriptome profiling and bioinformatics were used to identify a six-gene mRNA expression biomarker panel. The resulting risk prediction model was validated across clinical cohorts using both tissue and liquid biopsy specimens. Performance showed high accuracy for peritoneal recurrence, maintained efficacy in noninvasive liquid biopsy, and distinguished patients with peritoneal metastasis while detecting micrometastases efficiently.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/transcriptomics-based-liquid-biopsy-panel-for-early-non-invasive-identification-of-peritoneal-recurrence-and-micrometastasis-in-locally-advanced-gastric-cancer/342964/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/transcriptomics-based-liquid-biopsy-panel-for-early-non-invasive-identification-of-peritoneal-recurrence-and-micrometastasis-in-locally-advanced-gastric-cancer/342964.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study?","Question",{"text":112,"@type":113},"To develop a six-gene expression biomarker panel for early, noninvasive identification and risk stratification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the biomarker panel identified and built?",{"text":117,"@type":113},"The study used genome-wide transcriptome profiling and rigorous bioinformatics to identify six mRNAs, then built a risk prediction model incorporating the 6-mRNA panel with clinical features.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the model perform when switching from invasive sampling to liquid biopsy?",{"text":121,"@type":113},"The model retained predictive efficacy in noninvasive liquid biopsy, demonstrating a high AUC for peritoneal recurrence.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342964,1790254018,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Ding et al. J Exp Clin Cancer Res (2024) 43:181 [https://doi.org/10.1186/s13046-024-03098-5](https://doi.org/10.1186/s13046-024-03098-5)  \nJournal of Experimental & Clinical Cancer Research  \n RESEARCH Open Access  \nTranscriptomics-based liquid biopsy  \npanel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer  \nPing’an Ding1,2,3†, Haotian Wu1,2,3†, Jiaxiang Wu1,2,3†, Tongkun Li1,2,3†, Renjun Gu4,5, Lilong Zhang6,  \nPeigang Yang1,2,3, Honghai Guo1,2,3, Yuan Tian1,2,3, Jinchen He1,2,3, Jiaxuan Yang1,2,3, Ning Meng7, Xiaolong Li8, Lingjiao Meng9* and Qun Zhao1,2,3*  \nAbstract  \nBackground This study aimed to develop a novel six-gene expression biomarker panel to enhance the early detection and risk stratification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer (LAGC) . Methods We used genome-wide transcriptome profiling and rigorous bioinformatics to identify a six-gene expression biomarker panel. This panel was validated across multiple clinical cohorts using both tissue and liquid biopsy samples to predict peritoneal recurrence and micrometastasis in patients with LAGC.  \nResults Through genome-wide expression profiling, we identified six mRNAs and developed a risk prediction model using 196 samples from a surgical specimen training cohort. This model, incorporating a 6-mRNA panel with clinical features, demonstrated high predictive accuracy for peritoneal recurrence in gastric cancer patients, with an AUC of 0.966 (95% CI: 0 .944–0. 988) . Transitioning from invasive surgical or endoscopic biopsy to noninvasive liquid biopsy, the model retained its predictive efficacy (AUC = 0 . 963; 95% CI: 0 .926–1. 000) . Additionally, the 6-mRNA panel effectively differentiated patients with or without peritoneal metastasis in 95 peripheral blood specimens (AUC = 0 . 970; 95% CI: 0 .936–1. 000) and identified peritoneal micrometastases with a high efficiency (AUC = 0 . 941; 95% CI: 0 .874–1. 000) .  \nConclusions Our study provides a novel gene expression biomarker panel that significantly enhances early detection of peritoneal recurrence and micrometastasis in patients with LAGC. The RSA model’s predictive capability offers a promising tool for tailored treatment strategies, underscoring the importance of integrating molecular biomarkers with clinical parameters in precision oncology.  \nKeywords Gastric cancer, Peritoneal recurrence, Micrometastasis, Liquid biopsy, Transcriptomics panel  \n†Ping’an Ding, Haotian Wu, Jiaxiang Wu and Tongkun Li contributed equally to this work.  \n*Correspondence: Lingjiao Meng [ljmeng@hebmu.edu.cn](ljmeng@hebmu.edu.cn)[ ](ljmeng@hebmu.edu.cn)Qun Zhao [zhaoqun@hebmu.edu.cn](zhaoqun@hebmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativecom](http://creat","cbCaie5T4Sn63kto","https://ap.wps.com/l/cbCaie5T4Sn63kto","pdf",9934415,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Background","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To develop a six-gene expression biomarker panel for early, noninvasive identification and risk stratification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer.\"},{\"question\":\"How was the biomarker panel identified and built?\",\"answer\":\"The study used genome-wide transcriptome profiling and rigorous bioinformatics to identify six mRNAs, then built a risk prediction model incorporating the 6-mRNA panel with clinical features.\"},{\"question\":\"How did the model perform when switching from invasive sampling to liquid biopsy?\",\"answer\":\"The model retained predictive efficacy in noninvasive liquid biopsy, demonstrating a high AUC for peritoneal recurrence.\"}]","Transcriptomics-based liquid biopsy panel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer | PDF",1790049162,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c2514addc5b915c100b4c697afca231.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06b22d9b325dc9964cc7e2cd32e0154e.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a98590639c8e9fa300aa245100fb3c81.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1764f4a8afa2fff26e51a338f9d0cf79.webp",980,1301]